Report copyright - January 2011 - Biocon · Biosimilars partnership - Mylan Monoclonal Antibodies (MAb) Combines Biocon's R&D and manufacturing of novel biologics/bio-generics with Mylan’s regulatory
Please pass captcha verification before submit form